id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-D-0529-0033,FDA,FDA-2010-D-0529,Qualification Process for Drug Development Tools; Guidance for Industry; Availability; Correction,Notice,Notice of Availability,2020-12-11T05:00:00Z,2020,12,2020-12-11T05:00:00Z,,2020-12-11T13:39:39Z,2020-27288,0,0,090000648499804d
FDA-2010-D-0529-0031,FDA,FDA-2010-D-0529,Qualification Process for Drug Development Tools; Guidance for Industry; Availability,Notice,Notice of Availability,2020-11-25T05:00:00Z,2020,11,2020-11-25T05:00:00Z,,2020-11-25T14:16:53Z,2020-26051,0,0,090000648497584a
FDA-2010-D-0529-0032,FDA,FDA-2010-D-0529,Qualification Process for Drug Development Tools; Guidance for Industry and FDA Staff,Other,Guidance,2020-11-25T05:00:00Z,2020,11,2020-11-25T05:00:00Z,,2024-11-06T23:43:20Z,,1,0,0900006484975a81
FDA-2010-D-0529-0023,FDA,FDA-2010-D-0529,"Qualification Process for Drug Development Tools; Draft Guidance for
Industry; Availability",Notice,Notice of Availability,2019-12-16T05:00:00Z,2019,12,2019-12-16T05:00:00Z,2020-02-15T04:59:59Z,2020-02-15T02:02:17Z,2019-26994,0,0,0900006484212725
FDA-2010-D-0529-0024,FDA,FDA-2010-D-0529,Qualification Process for Drug Development Tools Guidance for Industry and FDA Staff DRAFT GUIDANCE,Other,Guidance,2019-12-13T05:00:00Z,2019,12,2019-12-13T05:00:00Z,,2024-11-12T23:14:31Z,,1,0,0900006484213f74
FDA-2010-D-0529-0021,FDA,FDA-2010-D-0529,"Guidance for Industry on Qualification Process for Drug Development Tools;
Availability",Notice,Notice of Availability,2014-01-07T05:00:00Z,2014,1,2014-01-07T05:00:00Z,,2014-01-07T18:40:42Z,2014-00028,0,0,09000064814f12aa
FDA-2010-D-0529-0022,FDA,FDA-2010-D-0529,Final Guidance re Qualification Process for Drug Development Tools,Other,Guidance,2014-01-07T05:00:00Z,2014,1,2014-01-07T05:00:00Z,,2024-11-07T23:01:06Z,,1,0,09000064814e90f0
FDA-2010-D-0529-0002,FDA,FDA-2010-D-0529,Qualification Process for Drug Development Tools; Draft Guidance,Other,GDL-Guidance (Supporting and Related Materials),2010-10-25T04:00:00Z,2010,10,2010-10-25T04:00:00Z,,2024-11-07T01:39:32Z,,1,0,0900006480b76cf1
FDA-2010-D-0529-0001,FDA,FDA-2010-D-0529,Draft Guidance for Industry on Qualification Process for Drug Development Tools; Availability,Notice,GDL-Guidance,2010-10-25T04:00:00Z,2010,10,2010-10-25T04:00:00Z,2011-01-25T04:59:59Z,2010-10-25T17:29:53Z,2010-26927,0,0,0900006480b7661a